Description
In this presentation, Professor Dan Perry, an orthopedic surgery expert at Alder Hey in Liverpool, discusses the relationship between medical guidelines, research, and treatment for slipped capital femoral epiphysis (SUFE). He begins by welcoming the audience and introducing the topic of SUFE, noting the different treatment options available in the UK: in situ pinning versus acute reduction through osteotomy. Professor Perry outlines the increasing incidence of these cases and highlights the significant guidelines established by NICE (National Institute for Health and Care Excellence) in 2015 that emphasize governance and registry requirements for acute treatments.
He reveals how recent studies have shown a rise in the use of acute fixation, leading to a surge in procedures resembling a 'mini epidemic.' To address the knowledge gap in treatment methods, a comprehensive study, referred to as the BOSS study (British Osteotomy for Slipped capital femoral epiphysis), was initiated with participation from 143 hospitals. This study serves to compare acute reduction and in situ pinning, noting that half of treated cases adopt each method.
Professor Perry emphasizes the responsibility of orthopedic surgeons to inform patients about available treatment options, as mandated by legal guidelines. He references the GIRFT (Getting It Right First Time) report, which recommends centralizing surgeries for severe SUFE to ensure the highest quality of care.
The talk culminates with a call to action, encouraging surgeons to collaborate and centralize treatment for severe cases at specialist centers. He stresses the need for ongoing research and mentorship in the field, particularly through the upcoming Big BOSS study, aimed at enhancing treatment protocols and ensuring optimal patient outcomes.